USPTO 2015–2025 USPTO PatentsView Foreign Corporation

WisTa Laboratories Ltd.

USPTO PatentsView assignee record - 36 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Wista ranks #8,966 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 12 technology areas.

#8,966
of 49,997 US assignees by volume
Top 36%
by Innovation Score (40.4/100)
20.1
avg claims per patent
-32%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8966 · Foreign Corporation #8,966 · 36 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 36 grants
  • UPPER-Q #8,966/49,997
  • PHOTO-FINISH fairlife
  • CPC-FOCUS A61P · 12 areas
  • INNOV-PAR 40.4/100
  • CLAIMS-DENSE 20.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -32% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: fairlife, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Wista

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Wista's Innovation Score is 40.4/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Wista's grants concentrate

WisTa Laboratories Ltd. is a focused PatentsView assignee: 12 CPC subclasses with 86.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2022. By volume, Wista sits between Voicebox Technologies Corporation and Adocia.

Wista's three-year grant acceleration

WisTa Laboratories Ltd. shows 6 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at WisTa's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows WisTa holds 36 patents at rank #8,965, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near WisTa

By rank, the assignees closest to #8,965 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in WisTa's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for WisTa, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Wista's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
WisTa Laboratories Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 11.1%
2016 3 8.3%
2017 5 13.9%
2018 3 8.3%
2019 4 11.1%
2020 2 5.6%
2021 5 13.9%
2022 1 2.8%
2023 1 2.8%
2024 4 11.1%
2025partial year 4 11.1%

Where it ranks

Overall rank by patents

#8,966

of 49,997 tracked assignees

Innovation Score

40.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

WisTa Laboratories Ltd.'s patent record in context - here's where to go next.

  • WisTa Laboratories Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 86.1% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #8,966 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare WisTa Laboratories Ltd. against Voicebox Technologies Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.